Literature DB >> 20126926

The role of oxidative stress in COPD: current concepts and perspectives.

Antonio George de Matos Cavalcante1, Pedro Felipe Carvalhedo de Bruin.   

Abstract

Worldwide, COPD is a major cause of morbidity and mortality. The clinical and functional manifestations of COPD result from lung injury occurring through various mechanisms, including oxidative stress, inflammation, protease-antiprotease imbalance and apoptosis. Oxidative stress is central to the pathogenesis of COPD, since it can directly damage lung structures and exacerbate the other mechanisms involved. The cellular and molecular events involved in such lung injury are believed to occur long before the clinical and functional expression of COPD. Although the use of bronchodilators is currently the principal treatment for COPD, bronchodilators have little or no effect on disease progression. A better understanding of the pathogenesis of COPD, together with renewed efforts in basic and clinical research, will allow the diagnosis of COPD at a pre-clinical stage and provide more appropriate monitoring of disease activity, as well as leading to the development of novel therapeutic agents that will effectively prevent the progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20126926     DOI: 10.1590/s1806-37132009001200011

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  14 in total

1.  Hyperoxia during one lung ventilation: inflammatory and oxidative responses.

Authors:  Alicia Olivant Fisher; Kamran Husain; Marla R Wolfson; Terrence L Hubert; Elena Rodriguez; Thomas H Shaffer; Mary C Theroux
Journal:  Pediatr Pulmonol       Date:  2012-03-19

2.  Oxidative stress and nutritional status in chronic obstructive pulmonary disease.

Authors:  Niraj Dhakal; Madhab Lamsal; Nirmal Baral; Shrijana Shrestha; Subodh Sagar Dhakal; Narendra Bhatta; Raju Kumar Dubey
Journal:  J Clin Diagn Res       Date:  2015-02-01

Review 3.  What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?

Authors:  Ivan Guerra de Araújo Freitas; Pedro Felipe Carvalhedo de Bruin; Lia Bittencourt; Veralice Meireles Sales de Bruin; Sérgio Tufik
Journal:  Sleep Breath       Date:  2015-02-26       Impact factor: 2.816

4.  Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.

Authors:  Davood Attaran; Shahrzad M Lari; Mohammad Towhidi; Hassan Ghobadi Marallu; Hossein Ayatollahi; Mohammad Khajehdaluee; Mostafa Ghanei; Reza Basiri
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

5.  Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.

Authors:  George K Acquaah-Mensah; Deepti Malhotra; Madhulika Vulimiri; Jason E McDermott; Shyam Biswal
Journal:  PLoS Comput Biol       Date:  2012-07-19       Impact factor: 4.475

6.  Changes in chemiluminescence of whole blood of COPD patients treated with Hypoxen and effects of C₆₀ fullerenes on blood chemiluminescence.

Authors:  Kirill N Novikov; Nadezhda G Berdnikova; Alexey K Novikov; Oksana Y Lyusina; Olga G Muhitova; Olga I Yablonskaya; Ha Do Minh; Vladimir L Voeikov
Journal:  Med Sci Monit       Date:  2012-02

Review 7.  Relationship between Dysphagia and Exacerbations in Chronic Obstructive Pulmonary Disease: A Literature Review.

Authors:  Eduardo Steidl; Carla Simone Ribeiro; Bruna Franciele Gonçalves; Natália Fernandes; Vívian Antunes; Renata Mancopes
Journal:  Int Arch Otorhinolaryngol       Date:  2014-11-06

8.  Effects and mechanism of bufei yishen formula in a rat chronic obstructive pulmonary disease model.

Authors:  Jiansheng Li; Liping Yang; Qin Yao; Ya Li; Yange Tian; Suyun Li; Suli Jiang; Ying Wang; Xinmin Li; Zheng Guo
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-14       Impact factor: 2.629

9.  Serum Uric Acid in Chronic Obstructive Pulmonary Disease: A Hospital Based Case Control Study.

Authors:  Rajlaxmi Sarangi; Nirupama Varadhan; Jyotirmayee Bahinipati; Asha Dhinakaran; Kandasamy Ravichandran
Journal:  J Clin Diagn Res       Date:  2017-09-01

10.  Effect of early treatment with transcutaneous electrical diaphragmatic stimulation (TEDS) on pulmonary inflammation induced by bleomycin.

Authors:  Laisa A Santos; Carlos A Silva; Maria L O Polacow
Journal:  Braz J Phys Ther       Date:  2013-11-14       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.